Our report on Corporate Social Responsibility focuses on areas which are unique to Zealand’s business as a research and development driven biotechnology company with a diverse range of strategic partnerships. The report is available on our website.
Zealand’s policies with regards to Corporate Social Responsibility (CSR) cover many areas of our operations. In 2013 Zealand updated its CSR status report describing the status and activities within the following areas:
- Labour practices & decent work;
- Occupational health & safety;
- Animal rights;
- Environmental sustainability;
- Anti-corruption & pharmaceutical ethics.
These focus areas are an amalgamation of existing Zealand values and policies together with the principles of the United Nations Global Compact where they apply to the scope of the company’s business.
The CSR report puts particular emphasis on those areas which are unique to Zealand’s business as a biotechnology and research corporation with a diverse range of strategic partnerships. However, given that we do not directly market or commercialize any medicinal products, there are many issues specific to the pharmaceutical industry which consequently do not fall within the scope of our CSR activities.
Zealand has in accordance with the Danish Financial Statements Act, section 99a, prepared a statutory report on CSR, which can be found on the company’s website: